Artemether/Lemefantrine

Alice M. Jenh, PharmD, Paul A. Pham, PharmD
Artemether/Lemefantrine is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or purchase a subscription.

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

Pediatrics Central

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Falciparum malaria, uncomplicated disease in geographic areas of known chloroquine resistance.
    • Not approved for patients with severe or complicated P. falciparum malaria.
  • Not approved for the prevention of malaria.

NON-FDA APPROVED USES

  • Vivax malaria: Limited efficacy observed in one Thai study: rapid parasite clearance observed with 4-dose regimen, relapse was common, suggesting minimal activity against the hypnozoite stage of P. vivax[4].

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: June 27, 2014

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Artemether/Lemefantrine ID - 540604 A1 - Jenh,Alice ,PharmD AU - Pham,Paul,PharmD Y1 - 2014/06/27/ BT - Johns Hopkins ABX Guide UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540604/all/Artemether_Lemefantrine PB - The Johns Hopkins University DB - Pediatrics Central DP - Unbound Medicine ER -